Home Bratislava Medical Journal 2013 Bratislava Medical Journal Vol.114, No.9, p.544-546, 2013

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.2

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.114, No.9, p.544-546, 2013

Title: Relapse of hyperthyroidism after hemithyroidectomy in concurrent medullary thyroid cancer and Graves’ disease
Author: Z. W. Meng, Y. J. Zhang, W. Li, T. Shi, S. G. Wu, J. Tan

Abstract: We present a rare case of concurrent medullary thyroid cancer (MTC) and relapse of Graves’ disease (GD). A 26-year-old Chinese female suffered from GD for 1 year. Physical examination demonstrated mildly diffuse goiter with a palpable 1.0 cm nodule in the right thyroid lobe and exophthalmos. Before hemithyroidectomy, calcitonin was elevated and thyroglobulin was normal. After surgery, histopathological findings proved coexistence of MTC and GD. 16 months later, GD relapsed and radioactive iodine 131 therapy was given. Meanwhile, postoperative monitoring showed well controlled calcitonin and carcinoembryonic antigen. Our lesson demonstrates although concomitant of MTC and GD is very rare, yet after hemithyroidectomy for the single nodular MTC lesion, remnant thyroid lobe could be the source of GD relapse very soon. More importantly, the relapse of GD and the following radioiodine therapy and radiation exposure could have been prevented if a better therapy plan of total thyroidectomy was adopted in the first place, instead of hemithyroidectomy (Tab. 1, Fig. 2, Ref. 11).

Keywords: medullary thyroid cancer, Graves’ disease, relapse, calcitonin, thyroidectomy.
Year: 2013, Volume: 114, Issue: 9 Page From: 544, Page To: 546
doi:10.4149/BLL_2013_114


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.